{"id":11110,"date":"2023-03-22T00:00:00","date_gmt":"2023-03-22T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/"},"modified":"2025-08-19T08:28:12","modified_gmt":"2025-08-19T13:28:12","slug":"avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/","title":{"rendered":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL)"},"content":{"rendered":"<p>La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.<sup>2&nbsp;&nbsp;<\/sup>Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs tissus, y compris la peau, la bouche, les yeux, les articulations, le foie, les poumons, l&rsquo;\u0153sophage et le tractus gastro-intestinal.<\/p>\n<p><a class=\"ButtonSimple\" href=\"https:\/\/sanoficanada.fr.mediaroom.com\/2023-03-21-Avis-de-conformite-emis-concernant-Rezurock-MC-comprimes-de-belumosudil\" target=\"_blank\" rel=\"noopener\">Lire la suite ici<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2&nbsp;&nbsp;Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[50,50,52,52],"tags":[],"class_list":["post-11110","post","type-post","status-publish","format-standard","hentry","category-news-events","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-03-22T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:12+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#blogposting\",\"name\":\"AVIS DE CONFORMIT\\u00c9 \\u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\\u00c9S DE B\\u00c9LUMOSUDIL) | My\\u00e9lome Canada\",\"headline\":\"AVIS DE CONFORMIT\\u00c9 \\u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\\u00c9S DE B\\u00c9LUMOSUDIL)\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2023-03-22T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#webpage\"},\"articleSection\":\"News &amp; Events, News &amp; Events, What's new at Myeloma Canada, What's new at Myeloma Canada, Facultatif, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"position\":3,\"name\":\"Nouvelles de My\\u00e9lome Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#listItem\",\"name\":\"AVIS DE CONFORMIT\\u00c9 \\u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\\u00c9S DE B\\u00c9LUMOSUDIL)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#listItem\",\"position\":4,\"name\":\"AVIS DE CONFORMIT\\u00c9 \\u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\\u00c9S DE B\\u00c9LUMOSUDIL)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/nouvelles-de-myelome-canada\\\/#listItem\",\"name\":\"Nouvelles de My\\u00e9lome Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/\",\"name\":\"AVIS DE CONFORMIT\\u00c9 \\u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\\u00c9S DE B\\u00c9LUMOSUDIL) | My\\u00e9lome Canada\",\"description\":\"La forme chronique de la r\\u00e9action du GVH est une complication qui peut survenir apr\\u00e8s une greffe de cellules souches allog\\u00e9niques, entra\\u00eenant une morbidit\\u00e9 et une mortalit\\u00e9 importantes.2 Dans la forme chronique de la r\\u00e9action du GVH, les cellules immunitaires greff\\u00e9es (greffon) attaquent les cellules du patient (h\\u00f4te), entra\\u00eenant une inflammation et une fibrose dans plusieurs\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/03\\\/22\\\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2023-03-22T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada","description":"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs","canonical_url":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#blogposting","name":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada","headline":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL)","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2023-03-22T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#webpage"},"articleSection":"News &amp; Events, News &amp; Events, What's new at Myeloma Canada, What's new at Myeloma Canada, Facultatif, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","position":2,"name":"Actualit\u00e9s et \u00e9v\u00e9nement","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","position":3,"name":"Nouvelles de My\u00e9lome Canada","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#listItem","name":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#listItem","position":4,"name":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL)","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/nouvelles-de-myelome-canada\/#listItem","name":"Nouvelles de My\u00e9lome Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/","name":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada","description":"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2023-03-22T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada","og:description":"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs","og:url":"https:\/\/myeloma.ca\/fr\/2023\/03\/22\/avis-de-conformite-emis-concernant-rezurockmc-comprimes-de-belumosudil\/","article:published_time":"2023-03-22T05:00:00+00:00","article:modified_time":"2025-08-19T13:28:12+00:00","twitter:card":"summary_large_image","twitter:title":"AVIS DE CONFORMIT\u00c9 \u00c9MIS CONCERNANT REZUROCK(MC) (COMPRIM\u00c9S DE B\u00c9LUMOSUDIL) | My\u00e9lome Canada","twitter:description":"La forme chronique de la r\u00e9action du GVH est une complication qui peut survenir apr\u00e8s une greffe de cellules souches allog\u00e9niques, entra\u00eenant une morbidit\u00e9 et une mortalit\u00e9 importantes.2 Dans la forme chronique de la r\u00e9action du GVH, les cellules immunitaires greff\u00e9es (greffon) attaquent les cellules du patient (h\u00f4te), entra\u00eenant une inflammation et une fibrose dans plusieurs"},"aioseo_meta_data":{"post_id":"11110","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-18 15:57:40","updated":"2026-04-30 07:09:44","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11110"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110\/revisions"}],"predecessor-version":[{"id":31266,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11110\/revisions\/31266"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}